Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: Development and validation of SYNTAX score II

The Lancet

Volumn 381, Issue 9867, 2013, Pages 639-650

  Farooq, Vasim ^a   Van Klaveren, David ^a   Steyerberg, Ewout W ^a   Meliga, Emanuele ^b   Vergouwe, Yvonne ^a   Chieffo, Alaide ^c   Kappetein, Arie Pieter ^a   Colombo, Antonio ^c   Holmes, David R ^d   MacK, Michael ^e   Feldman, Ted ^f   Morice, Marie Claude ^g   Ståhle, Elisabeth ^h   Onuma, Yoshinobu ^a   Morel, Marie Angèle ⁱ   Garcia Garcia, Hector M ^a,i   Van Es, Gerrit Anne ⁱ   Dawkins, Keith D ^j   Mohr, Friedrich W ^k   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MAURIZIANO HOSPITAL   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d MAYO CLINIC   (United States)

^e Heart Hospital Baylor Plano   (United States)

^f EVANSTON HOSPITAL   (United States)

^g Hospital Privé Jacques Cartier   (France)

^h UPPSALA UNIVERSITY HOSPITAL   (Sweden)

ⁱ CARDIALYSIS   (Netherlands)

^j BOSTON SCIENTIFIC CORPORATION   (United States)

^k UNIVERSITY OF LEIPZIG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL DECISION MAKING; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE REGISTRY; DRUG ELUTING STENT; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LEFT CORONARY ARTERY; LONG TERM CARE; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; POPULATION RESEARCH; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL ANATOMY; SURGICAL APPROACH; SYNTAX SCORE;

EID: 84874404357     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)60108-7     Document Type: Article

References (56)

1. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-72.
2. Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention 2009; 5: 50-56.
3. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 1: 219-27.
4. Morice MC, Serruys PW, Kappetein AP, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 2010; 121: 2645-53.
5. Ong AT, Serruys PW, Mohr FW, et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 2006; 151: 1194-204.
6. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 31: 2501-55.
7. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011; 58: e44-122.
8. Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013; 381: 629-38.
9. Farooq V, Serruys PW, Stone GW, Virmani R, Chieffo A, Fajadet J. Left main coronary artery disease. Percutaneous interventional cardiovascular medicine. In: The PCR-EAPCI Textbook, EUROPA edn. Toulouse, France: PCR Publishing, 2012: 329-405.
10. Serruys P W, Farooq V, Vranckx P, et al. A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX trial at 3 years. JACC Cardiovasc Interv 2012; 5: 606-17.
11. Roques F, Michel P, Goldstone AR, Nashef SA. The logistic EuroSCORE. Eur Heart J 2003; 24: 881-82.
12. Garg S, Sarno G, Garcia-Garcia HM, et al. A new tool for the risk stratification of patients with complex coronary artery disease: the clinical SYNTAX score. Circ Cardiovasc Interv 2010; 3: 317-26.
13. Chen S-L, Chen JP, Mintz G, et al. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting. J Am Coll Cardiol Interv 2010; 3: 632-41.
14. Farooq V, Brugaletta S, Serruys PW. Contemporary and evolving risk scoring algorithms for percutaneous coronary intervention. Heart 2011; 97: 1902-13.
15. Capodanno D, Miano M, Cincotta G, et al. EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention. Am Heart J 2010;159: 103-09.
16. Leaman DM, Brower RW, Meester GT, Serruys P, van den Brand M. Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation 1981; 63: 285-99.
17. Medina A, Suarez de Lezo J, Pan M. A new classification of coronary bifurcation lesions. Rev Esp Cardiol 2006; 59: 183.
18. Hamburger JN, Serruys PW, Scabra-Gomes R, et al. Recanalization of total coronary occlusions using a laser guidewire (the European TOTAL Surveillance Study). Am J Cardiol 1997; 80: 1419-23.
19. Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001; 344: 1117-24.
20. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
21. Harrell FE Jr, et al. Hmisc: Harrell Miscellaneous. R package version 3.8-3. 2012. http://CRAN.R-project.org/package=Hmisc.
22. Steyerberg EW. Clinical prediction models. a practical approach to development, validation, and updating. New York: Springer, 2009.
23. Farooq V, Vergouwe Y, Raber L, et al. Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the logistic clinical SYNTAX score. Eur Heart J 2012; 33: 3098-104.
24. Farooq V, Serruys PW, Bourantas C, et al. Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial. Eur Heart J 2012; 33: 3105-13.
25. Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer-Verlag, 2001.
26. Hougaard P. Frailty models for survival data. Lifetime Data Anal 1995; 1: 255-73.
27. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-72.
28. Chieffo A, Meliga E, Latib A, et al. Drug-eluting stent for left main coronary artery disease: the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. JACC Cardiovasc Intv 2012; 5: 718-27.
29. Little RJ, D'Agostino R, Cohen ML, et al. The prevention and treatment of missing data in clinical trials. N Engl J Med 2012; 367: 1355-60.
30. R Development Core Team. R: a language and environment for statistical computing. 2011. http://www.R-project.org.
31. Harrell FE Jr. rms: Regression Modeling Strategies. R package version 3.4-0. 2012. http://CRAN.R-project.org/package=rms.
32. Head S, Farooq V, Serruys PW, Kappetein AP. The SYNTAX score and its clinical implications. Heart (in press).
33. Park SJ, Kim YH, Park DW, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med 2011; 364: 1718-27.
34. Serruys PW, Farooq V. Is FREEDOM casting doubt on the SYNTAX score? N Engl J Med (in press).
35. Singh M, Holmes DR, Lennon RJ, Rihal CS. Development and validation of risk adjustment models for long-term mortality and myocardial infarction following percutaneous coronary interventions-clinical perspective. Circ Cardiovasc Interv 2010; 3: 423-30.
36. Shahian DM, O'Brien SM, Sheng S, et al. Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation 2012; 125: 1491-500.
37. Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010; 21: 128-38.
38. Tonelli M, Muntner P, Lloyd A, et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet 2012; 380: 807-14.
39. Fox CS, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 2012; 380: 1662-73.
40. Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one-to eight-year outcomes. J Am Coll Cardiol 2003; 41: 1293-304.
41. Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009; 373: 1190-97.
42. Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012; 367: 2375-84.
43. Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative effectiveness of revascularization strategies. N Engl J Med 2012; 366: 1467-76.
44. Chieffo A, Hoye A, Mauri F, et al. Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) initiative. EuroIntervention 2010; 5: 773-79.
45. Stefanini GG, Kalesan B, Pilgrim T, et al. Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. JACC Cardiovasc Interv 2012; 5: 301-10.
46. Lansky AJ, Ng VG, Maehara A, et al. Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. JACC Cardiovasc Imaging 2012; 5 (suppl 3): S62-72.
47. Ellis J, Mulligan I, Rowe J, Sackett DL. Inpatient general medicine is evidence based. A-Team, Nuffield Department of Clinical Medicine. Lancet 1995; 346: 407-10.
48. Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2012; 59: 857-81.
49. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008; 358: 331-41.
50. Daemen J, Kukreja N, Serruys PW. Drug-eluting stents vs coronary-artery bypass grafting. N Engl J Med 2008; 358: 2641-42.
51. Genereux P, Palmerini T, Caixeta A, et al. SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements. Circ Cardiovasc Interv 2011; 4: 553-61.
52. Papadopoulou SL, Girasis C, Dharampal A, et al. Tomography (MSCT) SYNTAX Score: a feasibility and reproducibility study. JACC Imaging (in press).
53. Palmerini T, Biondi-Zoccai G, Della Riva D, et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet 2012; 379: 1393-402.
54. Stefanini GG, Kalesan B, Serruys PW, et al. Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial. Lancet 2011; 378: 1940-48.
55. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007; 115: 2344-51.
56. de Boer SP, Lenzen MJ, Oemrawsingh RM, et al. Evaluating the 'all-comers' design: a comparison of participants in two 'all-comers' PCI trials with non-participants. Eur Heart J 2011; 32: 2161-67.